Showing posts with label Cabergoline. Show all posts
Showing posts with label Cabergoline. Show all posts

Tuesday, June 8, 2010

Quinagolide - a valuable treatment option for hyperprolactinaemia -- Barlier and Jaquet

Quinagolide - a valuable treatment option for hyperprolactinaemia -- Barlier and Jaquet 154 (2): 187 -- European Journal of Endocrinology

CAB doesn't seem to be getting the PRL level down as much as we'd like, even at 0.75mg x 4/week. We're considering switching to QUI (Quinagolide). QUI appears to offer similar effectiveness in most studies. In addition, it's not an ergot-derived drug, so it should not have some of the risks that Bromocriptine and CAB have.

Thursday, January 14, 2010

Cabergoline dosage

"Tumors of the pituitary gland and other hyperprolactinemic conditions: Initially 0.5 mg per week, slowly titrated to 4.5 mg per week, if necessary." -Wikipedia

"For disorders of high prolactin levels or pituitary tumors: Adults—0.25 milligram (mg) two times a week. Dose may be increased every four weeks as needed, according to body prolactin levels, up to 1 mg two times a week." -MayoClinic.com

Friday, January 8, 2010

Cabergoline background

Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment

Constant headache

Why the constant headache?
  • It doesn't seem to be caused by prolactinemia, because Pat has constant headache that does not seem correlated to her prolactin level... although her PRL level never drops below about 30.
  • It doesn't seem to be caused by the Cabergoline treatment, because when Pat's CAB treatment has been discontinued for a month or two at a time the headache persists.
  • Can headache result from distortion of the diaphragma sellae caused by intracranial pressure in patients with secondary empty sella syndrome?